S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7119 +0.14%
AFTER HRS · 19:20 ET
Market ClerkRecap
Wed Oct 21 · after hours2 signals today106 insider buys this week · $305.5MCIRO short report next: Oct 31The week ahead
SH
INSIDER · RYTM · RHYTHM PHARMACEUTICALS, INC. · CHIEF FINANCIAL OFFICER

Smith Hunter C

Every open-market transaction filed under this name, Aug 31 to Aug 31.

Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$6.6M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 31RYTMRHYTHM PHARMACEUTICALS, INC.Chief Financial OfficerSell28,188$106.20$3M—
Aug 31RYTMRHYTHM PHARMACEUTICALS, INC.Chief Financial OfficerSell11,514$105.37$1.2M—
Aug 31RYTMRHYTHM PHARMACEUTICALS, INC.Chief Financial OfficerSell23,072$104.59$2.4M—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.